Tag: AbCellera
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
